1 completed, 1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Immunomonitoring: new trials by email Literature Review of Immunomonitoring trials Research Report on Immunomonitoring
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection Immunomonitoring - Intra-abdominal Infection, Critical Illness | Recruiting | Central Hospital, Nancy, France | 100 | 2025-11-14 | 2026-02-09 | |
| Feasibility Study on the Characterization of the Immune Profile of Young Patients After Treatment for Breast Cancer Immunomonitoring - Breast Cancer | Unknown | University Hospital, Grenoble | 26 | 2020-06-15 | 2020-12-07 | |
| Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma IMA 950, Poly ICLC, Immunomonitoring - CNS Tumor, Adult | Phase 1 / Phase 2 | Completed | University Hospital, Geneva | 19 | 2013-08-01 | 2016-04-20 |
Breast Neoplasms (1) · Central Nervous System Neoplasms (1) · Critical Illness (1) · Glioblastoma (1) · Intraabdominal Infections (1) · Sepsis (1)
Central Hospital, Nancy, France (1) · University Hospital, Geneva (1) · University Hospital, Grenoble (1)
France (2) · Switzerland (1)
Leila Gofti-Laroche, PharmD (1) · Pierre-Yves Dietrich, Professor (1)